Bay Colony Advisory Group, Inc D Invitae Corp Transaction History

Bay Colony Advisory Group, Inc D

$580 Million
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	SELL	$0.42 - $0.72 $17,358 - $29,756	-41,329 Reduced 76.1%	12,978 $8,000
Q3 2023 Nov 13, 2023	SELL	$0.6 - $1.53 $14,205 - $36,222	-23,675 Reduced 30.36%	54,307 $32,000
Q2 2023 Aug 11, 2023	SELL	$1.05 - $1.63 $6,956 - $10,798	-6,625 Reduced 7.83%	77,982 $88,000
Q1 2023 Apr 27, 2023	SELL	$1.2 - $2.73 $1,050 - $2,388	-875 Reduced 1.02%	84,607 $114,000
Q4 2022 Feb 01, 2023	BUY	$1.71 - $3.61 $5,130 - $10,830	3,000 Added 3.64%	85,482 $158,000
Q3 2022 Oct 27, 2022	BUY	$1.9 - $8.63 $10,450 - $47,465	5,500 Added 7.14%	82,482 $203,000
Q2 2022 Aug 08, 2022	BUY	$2.13 - $9.01 $119,188 - $504,172	55,957 Added 266.15%	76,982 $146,000
Q1 2022 Apr 28, 2022	BUY	$6.28 - $15.59 $17,584 - $43,652	2,800 Added 15.36%	21,025 $168,000
Q4 2021 Jan 28, 2022	BUY	$14.7 - $28.67 $49,245 - $96,044	3,350 Added 22.52%	18,225 $278,000
Q3 2021 Nov 02, 2021	BUY	$24.31 - $33.6 $6,077 - $8,400	250 Added 1.71%	14,875 $423,000
Q1 2021 May 13, 2021	BUY	$33.06 - $56.93 $70,252 - $120,976	2,125 Added 17.0%	14,625 $559,000
Q4 2020 Feb 02, 2021	BUY	$39.09 - $57.4 $85,998 - $126,280	2,200 Added 21.36%	12,500 $523,000
Q3 2020 Nov 25, 2020	BUY	$28.43 - $44.67 $9,950 - $15,634	350 Added 3.52%	10,300 $447,000
Q2 2020 Jul 23, 2020	SELL	$11.71 - $30.29 $585 - $1,514	-50 Reduced 0.5%	9,950 $301,000
Q1 2020 Apr 17, 2020	BUY	$7.64 - $27.5 $76,400 - $275,000	10,000 New	10,000 $137,000
Q3 2019 Oct 25, 2019	SELL	$18.85 - $27.5 $211,120 - $308,000	-11,200 Closed	0 $0
Q2 2019 Jul 17, 2019	BUY	$17.37 - $26.27 $27,792 - $42,032	1,600 Added 16.67%	11,200 $263,000
Q1 2019 Apr 30, 2019	BUY	$10.65 - $25.75 $102,240 - $247,200	9,600 New	9,600 $221,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

2.12M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.

Account